Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension.

Journal of clinical epidemiology - 1 Jan 2007

Farahani Pendar, Dolovich Lisa, Levine Mitchell

Abstract excerpt

BACKGROUND AND OBJECTIVES: Although several candidate genes of Renin-Angiotensin-Aldosterone System (RAAS) have been investigated, the gene-drug relationship remains unclear. The objective was to appraise the elements of research methodology and explore potential biases, which may be contributing to discordant results in the gene-drug interaction assessment for RAAS. METHODS: Systematic review of studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin II Type 1 Receptor Blockers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antihypertensive Agents

Share to Hypertension

Share to Pharmacogenetics

Share to Renin-Angiotensin System

Share to Research Design

Source

Identifiers

PMID: 17161748
DOI: 10.1016/j.jclinepi.2006.04.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension.PMID 17161748Read ↗

Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system.Semantic proximity Read ↗

A review on the design and reporting of studies on drug-gene interaction.Semantic proximity Read ↗

Pharmacogenetics of antihypertensive treatment.Semantic proximity Read ↗

Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations.Semantic proximity Read ↗

Pharmacogenomics of renin angiotensin system inhibitors in coronary artery disease.Semantic proximity Read ↗

In silico Approach for Exploring the Role of AT1R Polymorphism on its Function, Structure and Drug InteractionsSemantic proximity Read ↗

Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy.Semantic proximity Read ↗

Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors.Semantic proximity Read ↗

Pharmacogenetics of antihypertensive drug responses.Semantic proximity Read ↗

A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women.Semantic proximity Read ↗

Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool.Semantic proximity Read ↗

Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.